» Articles » PMID: 36790809

Comparison of Simulated Outcomes of Colorectal Cancer Surgery at the Highest-Performing Vs Chosen Local Hospitals

Abstract

Importance: Variation in outcomes across hospitals adversely affects surgical patients. The use of high-quality hospitals varies by population, which may contribute to surgical disparities.

Objective: To simulate the implications of data-driven hospital selection for social welfare among patients who underwent colorectal cancer surgery.

Design, Setting, And Participants: This economic evaluation used the hospital inpatient file from the Florida Agency for Health Care Administration. Surgical outcomes of patients who were treated between January 1, 2016, and December 31, 2018 (training cohort), were used to estimate hospital performance. Costs and benefits of care at alternative hospitals were assessed in patients who were treated between January 1, 2019, and December 31, 2019 (testing cohort). The cohorts comprised patients 18 years or older who underwent elective colorectal resection for benign or malignant neoplasms. Data were analyzed from March to October 2022.

Exposures: Using hierarchical logistic regression, we estimated the implications of hospital selection for in-hospital mortality risk in patients in the training cohort. These estimates were applied to patients in the testing cohort using bayesian simulations to compare outcomes at each patient's highest-performing and chosen local hospitals. Analyses were stratified by race and ethnicity to evaluate the potential implications for equity.

Main Outcomes And Measures: The primary outcome was the mean patient-level change in social welfare, a composite measure balancing the value of reduced mortality with associated costs of care at higher-performing hospitals.

Results: A total of 21 098 patients (mean [SD] age, 67.3 [12.0] years; 10 782 males [51.1%]; 2232 Black [10.6%] and 18 866 White [89.4%] individuals) who were treated at 178 hospitals were included. A higher-quality local hospital was identified for 3057 of 5000 patients (61.1%) in the testing cohort. Selecting the highest-performing hospital was associated with a 26.5% (95% CI, 24.5%-29.0%) relative reduction and 0.24% (95% CI, 0.23%-0.25%) absolute reduction in mortality risk. A mean amount of $1953 (95% CI, $1744-$2162) was gained in social welfare per patient treated. Simulated reassignment to a higher-quality local hospital was associated with a 23.5% (95% CI, 19.3%-32.9%) relative reduction and 0.26% (95% CI, 0.21%-0.30%) absolute reduction in mortality risk for Black patients, with $2427 (95% CI, $1697-$3158) gained in social welfare.

Conclusions And Relevance: In this economic evaluation, using procedure-specific hospital performance as the primary factor in the selection of a local hospital for colorectal cancer surgery was associated with improved outcomes for both patients and society. Surgical outcomes data can be used to transform care and guide policy in colorectal cancer.

Citing Articles

Achieving Health Equity: Advancing Colorectal Surgery among Racial and Ethnic Minorities in America.

Overstreet D, Hollis R Clin Colon Rectal Surg. 2024; 38(1):34-40.

PMID: 39734714 PMC: 11679203. DOI: 10.1055/s-0044-1786532.

References
1.
Birkmeyer J, Siewers A, Marth N, Goodman D . Regionalization of high-risk surgery and implications for patient travel times. JAMA. 2003; 290(20):2703-8. DOI: 10.1001/jama.290.20.2703. View

2.
Yahanda A, Lafaro K, Spolverato G, Pawlik T . A Systematic Review of the Factors that Patients Use to Choose their Surgeon. World J Surg. 2015; 40(1):45-55. DOI: 10.1007/s00268-015-3246-7. View

3.
Symer M, Abelson J, Yeo H . Barriers to Regionalized Surgical Care: Public Perspective Survey and Geospatial Analysis. Ann Surg. 2017; 269(1):73-78. DOI: 10.1097/SLA.0000000000002556. View

4.
Breslin T, Morris A, Gu N, Wong S, Finlayson E, Banerjee M . Hospital factors and racial disparities in mortality after surgery for breast and colon cancer. J Clin Oncol. 2009; 27(24):3945-50. PMC: 2734396. DOI: 10.1200/JCO.2008.20.8546. View

5.
Adam M, Turner M, Sun Z, Kim J, Ezekian B, Migaly J . The appropriateness of 30-day mortality as a quality metric in colorectal cancer surgery. Am J Surg. 2017; 215(1):66-70. DOI: 10.1016/j.amjsurg.2017.04.018. View